Fast decreasing CRP is able to reflect the binding IL-6 ability of WBP216 directly since hepatic production of CRP is mainly mediated by IL-6 (Vermeire et al., 2004), while slow changing DAS28 tracks RA-related clinical efficacy closely. The gene discussed is IL6; the disease is rheumatoid arthritis.